Abbott Wins $1.67B Appeals Court Bid Against J&J

He who laughs last, laughs best. 

Abbott scored big in a US court of appeals when it reversed a two-year old jury result awarding its rival J&J $1.67 billion for supposedly infringing Centocor's patents around Remicade.  Abbott produces the rival drug Humira for treating rheumatoid arthritis patients.

Abbott Wins $1.67B Appeals Court Bid Against J&J // Pharmalot.

The court however ruled that Centocor's patents were invalid as they hadn't reduced claims for a 'human variable region' to practice, saying "a mere wish or plan for obtaining the claimed invention was not sufficient".  Oops! 

 

Posted by Bruce Lehr Feb 25th 2011.